Elkfork Partners’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$1.64M Sell
191,906
-60,456
-24% -$593K 0.04% 300
2019
Q2
$2.9M Buy
252,362
+43,604
+21% +$561K 0.07% 223
2019
Q1
$2.93M Buy
208,758
+143,528
+220% +$1.88M 0.07% 216
2018
Q4
$675K Buy
65,230
+35,420
+119% +$522K 0.02% 440
2018
Q3
$510K Hold
29,810
0.01% 589
2018
Q2
$537K Buy
29,810
+8,448
+40% +$169K 0.01% 509
2018
Q1
$374K Buy
21,362
+924
+5% +$19.3K 0.01% 612
2017
Q4
$470K Buy
20,438
+4,202
+26% +$87.1K 0.01% 550
2017
Q3
$340K Buy
16,236
+3,784
+30% +$69.7K 0.01% 589
2017
Q2
$251K Buy
12,452
+5,742
+86% +$125K 0.01% 630
2017
Q1
$163K Sell
6,710
-902
-12% -$24.3K 0.01% 631
2016
Q4
$205K Buy
+7,612
New +$188K 0.01% 565

Other funds holding PTEN

Elkfork Partners's PTEN Position: Q3 2019 in Review

Elkfork Partners reduced its Patterson-UTI (PTEN) stake by 24% in Q3 2019, selling an estimated $593K and leaving 191,906 shares worth $1.64M. The position accounts for 0.04% of the portfolio, ranked #300.

Elkfork Partners first reported a position in PTEN in Q4 2016 and has held it in 12 quarters since. The position peaked at $2.93M in Q1 2019. 268 funds tracked by Wall St. Rank hold PTEN as of Q3 2019.

  • Elkfork Partners held 191,906 shares of Patterson-UTI worth $1.64M as of Q3 2019.
  • Elkfork Partners sold 60,456 Patterson-UTI shares in Q3 2019, an estimated $593K.
  • Patterson-UTI made up 0.04% of Elkfork Partners's portfolio in Q3 2019, its #300 holding.
  • Elkfork Partners first reported a position in Patterson-UTI in Q4 2016 and has held it in 12 quarters since.
  • Elkfork Partners's Patterson-UTI position peaked at $2.93M in Q1 2019.
  • 268 funds tracked by Wall St. Rank held Patterson-UTI as of Q3 2019.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.